Psychotropic drug-use patterns: Reality versus ideal

Economics of Neuroscience

Volumn 3, Issue 2, 2001, Pages 66-68

  Stimmel, G L ^a   McCombs, J S ^a   Aiso, J Y ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CHLORPROMAZINE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL PRACTICE; CLINICAL STUDY; CONTROLLED STUDY; DATA BASE; DEPRESSION; DOSE TIME EFFECT RELATION; DRUG INDICATION; DRUG INFORMATION; DRUG USE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL DOCUMENTATION; MOOD; PRACTICE GUIDELINE; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOLOGY; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; STANDARDIZATION; TREATMENT OUTCOME; UNITED STATES;

EID: 0035060716     PISSN: 15270815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Practice guideline for major depressive disorder in adults
2. Mood disorders
3. Three year outcomes for maintenance therapies in recurrent depression
4. The texas medication algorithm project: Report of the Texas consensus conference panel on medication treatment of major depressive disorder
5. The Texas medication algorithm project patient and family education program: A consumer-guided initiative
6. The role of SSRI antidepressants for treating depressed patients in the California Medicaid (MediCal) program
7. Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations
8. Expert consensus treatment guidelines for schizophrenia: A guide for patients and families
9. Algorithms for the treatment of schizophrenia
10. Use patterns for antipsychotic medications in Medicaid patients with schizophrenia
11. Antipsychotic drug-use patterns and the cost of treating schizophrenia
12. The use of of conventional antipsychotic medications for patients with schizophrenia in a Medicaid population: Therapeutic and cost outcomes over two years
13. Practice guideline for the treatment of patients with bipolar disorder
14. Treatment algorithm use to optimize management of symptomatic patients with a history of mania
15. The role of the primary care physician in patients' adherence to antidepressant therapy
16. Facilitating compliance with antipsychotic medication
17. Clinical factors associated with treatment noncompliance in euthymic bipolar patients
18. Approaches to the enhancement of patient adherence to antidepressant medication treatment
19. Barriers to the diagnosis of depression in primary care
20. Patient and physician attitudes toward lithium